Location History:
- Clauire, FR (2013)
- Caluire, FR (2007 - 2018)
Company Filing History:
Years Active: 2007-2018
Title: Michèle Aguera: Innovator in Cancer Diagnosis and Treatment
Introduction
Michèle Aguera is a prominent inventor based in Caluire, France. She has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of cancers and paraneoplastic neurological syndromes. With a total of 4 patents to her name, Aguera's work is paving the way for advancements in cancer diagnostics.
Latest Patents
Aguera's latest patents include groundbreaking research on the Human ULIP/CRMP protein. This research focuses on a purified polypeptide, designated ULIP6, which comprises the amino acid sequence SEQ ID No. 2 or an epitopic fragment of said polypeptide, comprising the sequence SEQ ID No. 4. The patents provide not only the nucleic acid sequences but also antibodies to the polypeptide. Furthermore, they outline methods for diagnosing paraneoplastic neurological syndromes and for the early diagnosis of cancerous tumor formation.
Career Highlights
Aguera is affiliated with the Institut National de la Santé et de la Recherche Médicale, where she conducts her research. Her work has garnered attention for its potential impact on cancer treatment and diagnosis, showcasing her dedication to advancing medical science.
Collaborations
Some of her notable coworkers include Jean-Christophe Antoine and Marie-Françoise Belin. Their collaborative efforts contribute to the innovative research environment that Aguera thrives in.
Conclusion
Michèle Aguera's contributions to cancer research through her patents and collaborations highlight her role as a leading inventor in the medical field. Her work continues to inspire advancements in the diagnosis and treatment of serious health conditions.